Stockholm3 Blood Test Outperforms PSA

New research reveals a blood test called Stockholm3 that outperforms the standard PSA test at catching aggressive prostate cancer—spotting 90% of dangerous cases versus PSA’s 74%. The study tracked over 12,000 men for two years, showing Stockholm3’s ability to identify real threats without flooding patients with false alarms. While still in development and not yet FDA-approved in the U.S., this promising tool could revolutionize screening by reducing unnecessary biopsies and MRIs, catching deadly cancers earlier, and improving survival rates—all while easing patient anxiety and costs. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8b8e67b29efd827e